Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route

Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route

Human papillomavirus (HPV) causes cervical cancer among women and is associated with other anogenital cancers in men and women. Prophylactic particulate vaccines that are affordable, self-administered and efficacious could improve uptake of HPV vaccines world-wide. The goal of this research is to de...

Full description

Bibliographic Details
Main Authors: Trinh Phuong Vo, Gitika Panicker, Kimberly Braz-Gomes, Ashwin C. Parenky, Ira Rajbhandari, Mangalathu S. Rajeevan, Elizabeth R. Unger, Martin J. D’Souza, Mohammad N. Uddin
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Pharmaceuticals
Subjects:
human papillomavirus (HPV)
virus-like particle (VLP)
microparticles
particulate vaccines
transdermal
adjuvant
Online Access:https://www.mdpi.com/1424-8247/15/9/1128

Internet

https://www.mdpi.com/1424-8247/15/9/1128

Similar Items